权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

MITOCHONDRIAL GENOME ANALYSIS OF EPITHELIAL SEROUS OVARIAN CARCINOMA

上皮性浆液性卵巢癌的线粒体基因组分析

基本信息

批准号：
8037199
负责人：
Felix O Aikhionbare
金额：
$ 7万
依托单位：
MOREHOUSE SCHOOL OF MEDICINE
依托单位国家：
美国
项目类别：
财政年份：
2010
资助国家：
美国
起止时间：
2010-03-01 至 2013-02-28
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8037199
关键词：
Address African American Biological Models Cancer Patient Caucasians Caucasoid Race Characteristics Classification Clinical Complex Cystadenoma Development Diagnosis Diagnostic Diagnostic Neoplasm Staging Disease Disease Outcome Epithelial Epithelial Cells Epithelial ovarian cancer Gene Mutation Genes Genetic Genetic Polymorphism Goals Heterogeneity Histocompatibility Testing Histologic Human Individual Journals Knowledge Lead Link Malignant neoplasm of ovary Minority Mitochondria Mitochondrial DNA Mitochondrial Proteins Modality Molecular Molecular Profiling Mutation Outcome Ovarian Ovarian Diseases Ovarian Serous Adenocarcinoma Ovarian Serous Tumor Ovarian Tissue Ovary Oxidative Phosphorylation Pathology Patients Pattern Play Population Predictive Factor Predisposition Premalignant Process Protein Subunits Reactive Oxygen Species Reporting Research Role Serous Signal Transduction Staging Subgroup Technology Testing Tissues Tumor Subtype Tumor stage Two-Dimensional Gel Electrophoresis Variant Western Blotting Woman Work adenoma cancer cell cancer therapy carcinogenesis caucasian American clinically relevant improved mitochondrial DNA mutation mitochondrial genome mortality outcome forecast ovarian neoplasm oxidative DNA damage phrases protein expression public health relevance racial difference racial/ethnic difference research study tumor tumor progression

项目摘要

DESCRIPTION (provided by applicant): Patients with similar ovarian tumor characteristics display heterogeneity in the course and outcome of the disease. While a number of treatment modalities have been developed for ovarian cancer, we still are far from finding why there are a great deal of heterogeneity show by ovarian cancer patients in the course and outcome regarding the disease racial differences. Therefore, more research is needed not only to understand the basic processes that are subverted by stages of ovarian cancer cells to gain a proliferative advantage, also why there are a great deal of racial differences show by ovarian cancer patients in the course and outcome of the disease. The accumulation of ROS and oxidative DNA damage during the course of a lifetime may be deleterious and lead to specific mitochondrial genome alterations that may be involved in the development and progression of ovarian cancer. Our central hypothesis is that mtDNA gene profiling in serous ovarian cancer tissues will identify clinically relevant patterns of mutations and expression in histological serous tumor stages and subgroups of Caucasian and African-American serous ovarian cancer bearing patients. Specific aims are: (1) To determine and evaluate the role of mtDNA polymorphism/mutations play between African American and Caucasian patients susceptibility to invasive epithelial serous ovarian cancer. (2) To determine whether there are differences in the level of mitochondrial protein expression profiles between "early" stages of serous ovarian tumors and normal surrounding ovarian tissue from same individual patient of African-American and Caucasian origin. A combination of multiplatform of technologies will be performed in this application to accurately evaluate genetic changes in epithelial serous ovarian cancer subtypes and sub-classification of patients with similar disease. Results from this study should provide basic knowledge to the development of proper clinical tests for prediction of cancer patients' clinical outcome which is required for efficacious therapies. PUBLIC HEALTH RELEVANCE: A great deal of differences has been observed in the course and outcome of serous ovarian cancer with seemingly similar attributes, making application of appropriate therapies difficult. Delineating the mtDNA gene alterations in histologic epithelial serous ovarian cancer stages and sub-classification of patients (African-American and Caucasian) with similar disease, should lead to better understanding why this disease has higher mortality rate in African American than in the Caucasian population.

描述（由申请人提供）：具有相似卵巢肿瘤特征的患者在病程和结局方面表现出异质性。虽然已经开发了许多治疗卵巢癌的方法，但我们仍然远远没有找到为什么卵巢癌患者在病程和结局方面表现出大量的异质性，这与疾病的种族差异有关。因此，需要更多的研究，不仅要了解卵巢癌细胞阶段颠覆的基本过程，以获得增殖优势，还要了解为什么卵巢癌患者在疾病的过程和结果中表现出大量的种族差异。在一生中ROS的积累和氧化性DNA损伤可能是有害的，并导致特定的线粒体基因组改变，可能参与卵巢癌的发展和进展。我们的中心假设是，浆液性卵巢癌组织中的mtDNA基因谱将确定临床相关的突变模式和表达的组织学浆液性肿瘤阶段和亚组的白人和非洲裔美国人浆液性卵巢癌轴承患者。具体目标是：（1）确定和评估mtDNA多态性/突变在非裔美国人和白人患者对浸润性上皮性浆液性卵巢癌易感性中的作用。(2)确定来自非洲裔美国人和高加索人的同一个体患者的浆液性卵巢肿瘤的“早期”阶段和正常周围卵巢组织之间的线粒体蛋白表达谱水平是否存在差异。在本申请中将进行多平台技术的组合，以准确评价上皮性浆液性卵巢癌亚型的遗传变化和类似疾病患者的亚类。这项研究的结果应该为开发适当的临床测试提供基础知识，以预测癌症患者的临床结果，这是有效治疗所需的。公共卫生关系：在具有看似相似属性的浆液性卵巢癌的过程和结果中观察到了大量差异，使得应用适当的治疗变得困难。描述组织学上皮性浆液性卵巢癌阶段和类似疾病患者（非洲裔美国人和高加索人）的亚分类中mtDNA基因的改变，应该更好地理解为什么这种疾病在非洲裔美国人中的死亡率高于高加索人。